Studies Included	Comments	Conclusions*
5 studies, all restricted to women at high genetic risk.	Evidence on long-term clinical outcomes not available. Hence, sensitivity and specificity are limited outcome measures.	MRI screening of women at high risk is recommended. High-risk is defined as confirmed presence of BRCA1/2 mutation, or known mutation in relatives, or multiple affected 1st degree relatives, often at young ages and with bilateral disease.

^*BRCA1/2 indicates the presence of either a BRCA1 and/or BRCA2 gene mutation.